Men's Weekly

.

AIM Vaccine submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine

Achieve quality upgrade of traditional human diploid wild seedlings

HONG KONG SAR - Media OutReach Newswire - 27 March 2024 - AIM Vaccine Co., Ltd. (the "AIM Vaccine", together with its subsidiaries, the "Group") is pleased to announce that the Group has submitted the pre-application for clinical trials for novel-process highly-effective human diploid rabies vaccine on March 24, 2024.


Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 18

Notice: Undefined offset: 1 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 2 in /httpdocs/templates/gk_university/html/pagination.php on line 34

Notice: Undefined offset: 3 in /httpdocs/templates/gk_university/html/pagination.php on line 34